JPRN-UMIN000010805招募中2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003) - A Phase II study of PEM/Bev in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-sq NSCLC (ALCT003)
Department of Respiratory Medicine Kyorin Univercity Hospital0 个研究点目标入组 25 人开始时间: 2013年5月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)active double cancer 2)clinically significant infectious disease 3)history of gross hemoptysis (2.5ml) 4)regular use of aspirin 5)history of diverticulitis or clinically significant diverticular disease 6)clinically significant cardiovascular disease and DVT 7)medically uncontrolled hypertension and diabetes 8)active or symptomatic interstitial lung disease 9)Patients with the plan of operation or thoracic irradiation 10)Patients with wound that has not quite healed 11)pregnancy or lactation
研究者
相似试验
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.JPRN-UMIN000008124iigata Lung Cancer Treatment Group25
已完成
2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)non-small cell lung cancerJPRN-UMIN000009539OSAKA-LCSG45
招募中
2 期
A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutatioon-small cell lung cancerJPRN-UMIN000008032Toho University Omori Medical Center15